Randomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocol

Leticia Krauss-Silva, Maria Elizabeth L Moreira, Mariane B Alves, Maria R Rezende, Alcione Braga, Karla G Camacho, Maria Rosa R Batista, Clarisse Savastano, Antonio Almada-Horta, Fernando Guerra, Leticia Krauss-Silva, Maria Elizabeth L Moreira, Mariane B Alves, Maria R Rezende, Alcione Braga, Karla G Camacho, Maria Rosa R Batista, Clarisse Savastano, Antonio Almada-Horta, Fernando Guerra

Abstract

Background: Spontaneous preterm deliveries that occur before the 34th week of gestation, and particularly before the 32nd week of gestation, have been strongly associated to intrauterine infection, ascending from vagina, and represent the largest portion of neonatal deaths and neurological problems. Bacterial vaginosis, characterized by a diminished or absent flora of lactobacilli and increased colonization of several anaerobic or facultative microorganisms, increases two times the risk of preterm delivery before the 34th week. Trials of antibiotics failed to show efficacy and effectiveness against spontaneous preterm birth related to bacterial vaginosis. Some studies indicate benefit from selected probiotics to treat genitourinary infections, including bacterial vaginosis.

Objective: The purpose of this study is to evaluate the effectiveness of the early administration of selected probiotics to pregnant women with asymptomatic bacterial vaginosis/intermediate degree infection to reduce the occurrence of spontaneous preterm delivery and related neonatal mortality and morbidity.

Methods/design: Women attending public prenatal care services in Rio de Janeiro will be screened to select asymptomatic pregnant women, less than 20 weeks' gestation, with no indication of elective preterm delivery. Those with vaginal pH > = 4.5 and a Nugent score between 4 and 10 (intermediate degree infection or bacterial vaginosis) will be randomized to either the placebo or the intervention group, after written informed consent. Intervention consists in the use of probiotics, Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, 2 capsules a day, each capsule containing more than one million bacilli of each strain, for 6-12 weeks, up to the 24th-25th wk of gestation. Ancillary analyses include quantification of selected cervicovaginal cytokines and genotyping of selected polymorphisms. The randomization process is stratified for history of preterm delivery and blocked. Allocation concealment was designed as well as blinding of women, caregivers and outcome evaluators. The study will be supervised by an independent monitoring committee. Outcomes under study are preterm delivery (< 34- < 32 weeks of gestation) and associated neonatal complications: early neonatal sepsis, bronchopulmonary dysplasia, periventricular leukomalacia, necrotizing enterocolitis, and prematurity-related retinopathy; definitions were adapted from those recommended by the 2002 version of the Vermont-Oxford Network. Trial registration at NIH register: NCT00303082.

Figures

Figure 1
Figure 1
Flow diagram according to the trial protocol.

References

    1. Agency for Healthcare Research and Quality. Management of preterm labor. Evidence report/technology assessment n. 18 AHRQ public. 2000. n. 01-E021.
    1. Leal MC, Gama SGN, Campos MR. Fatores associados à morbi-mortalidade perinatal em uma amostra de maternidades públicas e privadas do município do Rio deJaneiro, 1999-2001. Cadernos de Saúde Pública. 2004;20(Supl. 1):S20–S33.
    1. Campos MR, Leal MC, Souza Jr PR, Cunha CB. Consistência entre fontes de dados e confiabilidade inter-observador do estudo da morbi-mortalidade e atenção peri e neonatal no município do Rio de Janeiro. Cadernos de Saúde Pública. 2004;20(Supl. 1):S34–S43.
    1. Berkowitz GS, Prince CB, Lapinski RH. Risk factors for preterm birth subtypes. Epidemiology. 1998;9(3):279–285. doi: 10.1097/00001648-199805000-00011.
    1. Goldenberg RL, Andrews WW, Hauth JC. Choriodecidual infection and preterm birth. Nutrition Reviews. 2002;60(5):S19–S25. doi: 10.1301/00296640260130696.
    1. Romero R, Espinoza J, Chaiworapongsa T, Kalache K. Infections and prematurity and the role of preventive strategies. Semin Neonatol. 2002;7:259–274.
    1. Lewit EM, Baker LS, Corman H. The direct cost of low birth weight. The future of children. The Woodrow Wilson School of Public and International Affairs. 2004.
    1. Goldenberg RL, Iams JD, Mercer BM, Meis P, Moawad A, Das A, Copper R, Johnson F. for the national Institute of Child Health and Human Development Network. What we have learned about the predictors of preterm birth. Seminars in Perinatology. 2003;27(3):185–93. doi: 10.1016/S0146-0005(03)00017-X.
    1. Mercer BM, Goldenberg RL, Das A. The preterm prediction study: A clinical risk assesment system. Am J Obstet Gynecol. 1996;174(6):1885–1895. doi: 10.1016/S0002-9378(96)70225-9.
    1. Klebanoff MA, Hauth JC, MacPherson CA, Carey JC, Heine RP, Wapner RJ, Iams JD, Moawad A, Miodovnik M, Sibai BM, van Dorsten JP, Dombrowski MP. for the National Institute for Child Health and Development Maternal Fetal Medicine Units Network. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. American Journal of Obstetrics and Gynecology. 2004;190(2):363–70. doi: 10.1016/j.ajog.2003.08.020.
    1. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, Jun JK. The relationships among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration amniotic fluid infection and neonatal sepsis. Am J Obstet Gynecol. 2000;183(5):1124–9. doi: 10.1067/mob.2000.109035.
    1. Yoon BH, Romero R, Kim KS. Transactions of the nineteenth annual meeting of the society for maternal-fetal medicine. Am J Obstet Gynecol. 1999;181(4):773–9. doi: 10.1016/S0002-9378(99)70299-1.
    1. Yoon BH, Romero R, Yang SH. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol. 1996;174(5):1433–40. doi: 10.1016/S0002-9378(96)70585-9.
    1. Gomez R, Romero R, Ghezzi F. The Fetal Inflammatory Response Syndrome. Am J Obstet Gynecol. 1998;179(1):194–202. doi: 10.1016/S0002-9378(98)70272-8.
    1. Cauci S. Vaginal Immunity in Bacterial Vaginosis. Current Infectious Disease Reports. 2004;6(6):450–6. doi: 10.1007/s11908-004-0064-8.
    1. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of Clinical Microbiology. 1991;29(2):297–301.
    1. Schwebke JR, Hillier SL, Sobel JD. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol. 1996;88(4):573–6. doi: 10.1016/0029-7844(96)00233-5.
    1. Meis PJ, Goldenberg RL, Mercer B. The Preterm Prediction Study: significance of vaginal infections. Am J Obst Gynecol. 1995;173:1231–5. doi: 10.1016/0002-9378(95)91360-2.
    1. Iams JD, Goldenberg RL, Mercer BM, Moawad A, Meis PJ, Das AF, Caritis SN, Miodovnik M, Menard MK, Thurnau GR, Dombrowski M, Roberts J. for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. The Preterm Prediction Study: Can low-risk women destined for spontaneus preterm birth be identified? Am J Obstet Gynecol. 2001;184(4):652–655. doi: 10.1067/mob.2001.111248.
    1. Cauci S, Hitti J, Noonan C. Vaginal hydrolytic enzymes immunoglobulin A against Gardenerella vaginalis toxin and risk of early preterm birth among women in preterm labor with bacterial vaginosis or intermediate flora. Am J Obstet Gynecol. 2002;187(4):877–881. doi: 10.1067/mob.2002.127454.
    1. Hauth JC, Macpherson C, Carey JC, Klebanoff MA, Hillier SL, Ernest JM, Leveno KJ, Wapner R, Varner M, Trout W, Moawad A, Sibai BM. for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Early pregnancy threshold vagina ph and gram stain scores predictive of subsequent preterm birth in asymptomatic women. Am J Obstet Gynecol. 2003;188(3):831–5. doi: 10.1067/mob.2003.184.
    1. Simhan HN, Caritis NS, Krohn MA, Hillier SL. Elevated Vaginal pH And Neutrophils Are Associated Strongly Early Spontaneous Preterm Birth. Am J Obstet Gynecol. 2003;189(4):1150–4. doi: 10.1067/S0002-9378(03)00582-9.
    1. McGregor JÁ, French JI, Richter R. Cervicovaginal microflora and pregnancy outcome: results of doble-blind, placebo-controlled trial of erythromycin. Am J Obstet Gynecol. 1990;163(5 Pt 1):1580–91.
    1. Hauth JC, Goldenberg RL, Andrews WW. Reduced Incidence Of Preterm Delivery With Metronidazole and Erythromycin in Women With Bacterial Vaginosis. N Engl J Med. 1995;333(26):1732–6. doi: 10.1056/NEJM199512283332603.
    1. Carey JC, Klebanoff MA, Hauth JC, Hillier SL,Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ, Wapner R, Varner M, Trout W, Moawad A, Sibai BM, Miodovnik M, Dombrowski M, O'Sullivan MJ, van Dorsten JP, Langer O, Roberts J. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal Fetal Medicine Units. N Engl J Med. 2000;343(8):534–40. doi: 10.1056/NEJM200002243420802.
    1. Andrews WW, Sibai BM, Thom EA, Dudley D, Ernest JM, McNellis D, Leveno KJ, Wapmer R, Moawad A, O'Sullivan MJ, Caritis SN, Iams JD, Langer O, Miodovnik M, Dombrowski M. for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol. 2003;101(5):847–55. doi: 10.1016/S0029-7844(03)00172-8.
    1. Simhan HN, Caritis SN, Krohn MA, Tejada BM, Landers DV, Hillier SL. Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol. 2003;189(2):560–7. doi: 10.1067/S0002-9378(03)00518-0.
    1. Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G. Bacterial Vaginosis. The inflammatory response and the preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol. 2004;190(6):1509–19. doi: 10.1016/j.ajog.2004.01.002.
    1. Klein LL, Gibbs R. Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol. 2004;190:1493–502. doi: 10.1016/j.ajog.2004.03.014.
    1. Isolauri E, Salminen S, Ouwehand AC. Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol. 2004;18(2):299–313. doi: 10.1016/j.bpg.2003.10.006.
    1. Vrese M, Schrezenmeir J. Probiotics and non-intestinal infectious conditions. Br J Nutr. 2002;88(Suppl 1):S59–S66. doi: 10.1079/BJN2002630.
    1. Reid G, Devillard E. Probiotics for mother and child. J Clin Gastroenterol. 2004;38(Suppl 2):S94–S101. doi: 10.1097/01.mcg.0000128923.68543.7f.
    1. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol. 2003;189(4):1202–8. doi: 10.1067/S0002-9378(03)00495-2.
    1. Reid G, Charbonneau D, Erb J, Kochanowski, Beuerman D, Poehner R, Bruce AW. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbio. 2003;35:131–4. doi: 10.1016/S0928-8244(02)00465-0.
    1. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and mantain a normal vaginal flora. FEMS Immunol Med Microbio. 2001;32:37–41. doi: 10.1111/j.1574-695X.2001.tb00531.x.
    1. Reid G, Bruce AW. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis. 2001;183(Suppl 1):S77–80. doi: 10.1086/318841.
    1. Reid G, Bruce AW, Fraser N. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbio. 2001;30:49–52. doi: 10.1111/j.1574-695X.2001.tb01549.x.
    1. Shalev E. Ingestion of probiotics: Optional treatment of bacterial vaginosis in pregnancy. IMAJ. 2002;4:357–60.
    1. Nenadic DB, Pavlovic MD. Cervical fluid in pregnant women: Relation to vaginal wet mount findings and polymorphonuclear leukocyte counts. Eur J Obstet Gynecol Reprod Biol. 2006;140(2):165–170. doi: 10.1016/j.ejogrb.2008.02.020.
    1. Cauci S, Gauschino S, Aloysio D, Driussi S, De Santo D, Penacchioni P, Quadrifoglio F. Interrelationships of interleukin-8 with interleukin-1β and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod. 2003;9(1):53–8. doi: 10.1093/molehr/gag003.
    1. Cauci S, Driussi S, Monte R, Lanzafame P, Pitzus E, Quadrifoglio F. Immunoglobulin A response against Gardenerella vaginalis hemolysin and sialidase activity in bacterial vaginosis. Am J Obstet Gynecol. 1998;178:511–515. doi: 10.1016/S0002-9378(98)70430-2.
    1. Cauci S, Mc Gregor J, Thorsen P, Grove J, Guaschino S. Combination of vaginal pH with vaginal sialidase and prolidase activities for prediction of low birth weight and preterm birth. Am J Obstet Gynecol. 2005;192:489–96. doi: 10.1016/j.ajog.2004.07.023.
    1. Cauci S, Scrimin F, Driussi S, Ceccone S, Monte R, Fant L, Quadrifoglio F. Specific immune response against Gardenerella vaginalis hemolysin in patients with bacterial vaginosis. Am J Obstet Gynecol. 1996;175(6):1601–5. doi: 10.1016/S0002-9378(96)70112-6.
    1. Cauci S, Monte R, Driussi S, Lanzafame P, Quadrifoglio F. Impairment of the mucosal immune system: IgA and IgM cleavage detected in vaginal washings of a subgroup of patients with bacterial vaginosis. Am J Obstet Gynecol. 1998;178:1698–706. doi: 10.1016/S0002-9378(98)70430-2.
    1. Yoon BH, Romero R, Moon J, Chaiworapongsa T, Espinoza J, Kim YM, Edwin S, Kim JC, Camacho N, Bujold E, Gomez R. Differences In The Fetal Interleukin-6 Response To Microbial In of the Amniotic Cavity Between Term and Preterm Gestation. J Matern Fetal Neonatal Med. 2003;13(1):32–8.
    1. Hitti J, Hillier SL, Agnew KJ, Krohn MA, Reisner DP, Eschenbach DA. Vaginal indicators of amniotic fluid infection in preterm labor. Obstet Gynecol. 2001;97(2):211–9. doi: 10.1016/S0029-7844(00)01146-7.
    1. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet and Gynecol. 1998;179(10):186–93. doi: 10.1016/S0002-9378(98)70271-6.
    1. Ghezzi F, Gomez R, Romero R, Yoon BH, Edwin SS, David C, Janisse J, Mazor M. Elevated Interleukin-8 Concentrations In Amniotic Fluid Of Mothers whose Neonates Subsequently Develop Bronchopulmonary Dysplasia. Eur J Obstet Gynecol Reprod Biol. 1998;78(1):5–10. doi: 10.1016/S0301-2115(97)00236-4.
    1. Yoon BH, Jun JK, Romero R. Amniotic fluid inflammatory cytokines (interleukin-6, interleukine-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 1997;177(91):19–26. doi: 10.1016/S0002-9378(97)70432-0.
    1. Genc MR, Witkin SS, Delaney ML, Paraskevas LR, Tuomala RE, Norwitz ER, Onderdonk AB. A disproportionate increase in IL-1B over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth. Am J Obstetrics Gynecology. 2004;190(5):1191–1197.
    1. Macones GA, Parry S, Elkousy M, Clothier B, Ural SH, Strauss JF. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstetrics Gynecology. 2004;190(6):1504–1508. doi: 10.1016/j.ajog.2004.01.001.
    1. Simhan HN, Krohn MA, Seevi A. Tumor Necrosis Factor - Alpha Promoter Gene Polymorphism - Chorioamnionitis. Obstet Gynecol. 2003;102(1):162–6. doi: 10.1016/S0029-7844(03)00406-X.
    1. Simhan HN, Krohn MA, Roberts JM. Interleukin-6 Promoter - 174 Polimorphism and Spontaneous Preterm Birth. Am J Obstet Gynecol. 2003;189(4):915–8. doi: 10.1067/S0002-9378(03)00843-3.
    1. Annels MF, Hart PH, Mullighan. Interleukins-1, -4, -6, -10, tumor necrosis factor transforming grouth factor -β, FAZ ans mannose-biding protein C gene polymorphisms in Australian women: Risk of preterm birth. Am J Obstet Gynecol. 2004;191:2056–67. doi: 10.1016/j.ajog.2004.04.021.
    1. Larsen B, Monif GR. Understanding the bacterial flora of the female genital tract. Clin Infect Dis. 2001;32(4):e69–77. doi: 10.1086/318710.
    1. Food and Agriculture Organization (FAO) of the United Nations and World Health Organization (WHO) Guidelines for the evaluation of probiotics in food report of a joint fao/who working group on drafting guidelines for the evaluation of probiotics in food. London Ontario; 2002.
    1. Famularo G, Pieluigi M, Coccia R, Mastroiacovo P, De Simone C. Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Med Hypotheses. 2001;56(4):421–30. doi: 10.1054/mehy.2000.1195.
    1. Reid G. The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol. 1999;65(9):3763–6.
    1. McLean NW, Rosenstein IJ. Characterization and selection of a Lactobacillus species to recolonize the vagina of women with recurrent bacterial vaginosis. J Med Microbiol. 2000;49:543–52.
    1. Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A. Lactic acid bacteria inhibit Th2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol. 2002;110(4):617–23. doi: 10.1067/mai.2002.128528.
    1. Rautava S, Kalliomäki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol. 2002;109:119–21. doi: 10.1067/mai.2002.120273.
    1. Weiss NS. In: Modern Epidemiology. 2. Rothman KJ, Greenland S, editor. Philadephia: Lippincott-Raven; 1998. Clinical Epidemiology.
    1. Morrison AS. In: Modern Epidemiology. 2. Rothman KJ Greenland S, editor. Philadephia: Lippincott-Raven; 1998. Screening.
    1. Donders GGG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. Int J Obstetrics and Gynaecology. 2002;109:34–43.
    1. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press; 1989.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera